{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:40:02Z","timestamp":1791333602131,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96383-y","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T17:02:02Z","timestamp":1744218122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antibiotic therapy and clinical outcomes of penicillin-susceptible Staphylococcus aureus (PSSA) bloodstream infection (BSI): a ten-year retrospective cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Zheng Hong","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sock Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Tong","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Vasoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby E.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"96383_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SYC Tong","year":"2015","unstructured":"Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L. & Fowler, V. G. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 28, 603\u2013661 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"96383_CR2","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmi.2022.03.015","volume":"28","author":"AD Bai","year":"2022","unstructured":"Bai, A. D. et al. Staphylococcus aureus bacteraemia mortality: A systematic review and meta-analysis. Clin. Microbiol. Infect. 28, 1076\u20131084 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"96383_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1126\/science.99.2579.452","volume":"99","author":"WMM Kirby","year":"1944","unstructured":"Kirby, W. M. M. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science 99, 452\u2013453 (1944).","journal-title":"Science"},{"key":"96383_CR4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI18535","volume":"111","author":"FD Lowy","year":"2003","unstructured":"Lowy, F. D. Antimicrobial resistance: The example of Staphylococcus aureus. J. Clin. Invest. 111, 1265\u20131273 (2003).","journal-title":"J. Clin. Invest."},{"key":"96383_CR5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1469-0691.2010.03425.x","volume":"17","author":"M Paul","year":"2011","unstructured":"Paul, M. et al. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?. Clin. Microbiol. Infect. 17, 1581\u20131586 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"96383_CR6","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.amjmed.2016.01.048","volume":"129","author":"MP Cheng","year":"2016","unstructured":"Cheng, M. P., Ren\u00e9, P., Cheng, A. P. & Lee, T. C. Back to the future: Penicillin-susceptible staphylococcus aureus. Am. J. Med. 129, 1331\u20131333 (2016).","journal-title":"Am. J. Med."},{"key":"96383_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jinf.2016.05.011","volume":"73","author":"F Resman","year":"2016","unstructured":"Resman, F., Thegerstr\u00f6m, J., M\u00e5nsson, F., Ahl, J. & Tham, J. The prevalence, population structure and screening test specificity of penicillin-susceptible staphylococcus aureus bacteremia isolates in Malm\u00f6. Sweden. J. Infect. 73, 129\u2013135 (2016).","journal-title":"Sweden. J. Infect."},{"key":"96383_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/JCM.03109-15","volume":"54","author":"SS Richter","year":"2016","unstructured":"Richter, S. S. et al. Detection and prevalence of penicillin-susceptible staphylococcus aureus in the united states in 2013. J. Clin. Microbiol. 54, 812\u2013814 (2016).","journal-title":"J. Clin. Microbiol."},{"key":"96383_CR9","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/jac\/dkv270","volume":"70","author":"MR Chabot","year":"2015","unstructured":"Chabot, M. R., Stefan, M. S., Friderici, J., Schimmel, J. & Larioza, J. Reappearance and treatment of penicillin-susceptible Staphylococcus aureus in a tertiary medical centre. J. Antimicrob. Chemother. 70, 3353\u20133356. https:\/\/doi.org\/10.1093\/jac\/dkv270 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"96383_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/22221751.2022.2027218","volume":"11","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Genomic epidemiology and characterisation of penicillin-sensitive staphylococcus aureus isolates from invasive bloodstream infections in China: An increasing prevalence and higher diversity in genetic typing be revealed. Emerg. Microbes Infect. 11, 326\u2013336 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"96383_CR11","doi-asserted-by":"publisher","first-page":"e00680","DOI":"10.1128\/AAC.00680-18","volume":"62","author":"G Butler-Laporte","year":"2018","unstructured":"Butler-Laporte, G., Lee, T. C. & Cheng, M. P. Increasing rates of penicillin sensitivity in staphylococcus aureus. Antimicrob. Agents Chemother. 62, e00680-e718 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"96383_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106567","volume":"59","author":"M Hagstrand Aldman","year":"2022","unstructured":"Hagstrand Aldman, M., Kavyani, R., Kahn, F. & P\u00e5hlman, L. I. Treatment outcome with penicillin G or cloxacillin in penicillin-susceptible Staphylococcus aureus bacteraemia: A retrospective cohort study. Int. J. Antimicrob. Agents 59, 106567 (2022).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"96383_CR13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1128\/JCM.03068-13","volume":"52","author":"LE Papanicolas","year":"2014","unstructured":"Papanicolas, L. E., Bell, J. M. & Bastian, I. Performance of phenotypic tests for detection of penicillinase in staphylococcus aureus isolates from australia. J. Clin. Microbiol. 52, 1136\u20131138 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"96383_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1128\/JCM.03413-13","volume":"52","author":"LA Pereira","year":"2014","unstructured":"Pereira, L. A., Harnett, G. B., Hodge, M. M., Cattell, J. A. & Speers, D. J. Real-time pcr assay for detection of blaz genes in staphylococcus aureus clinical isolates. J. Clin. Microbiol. 52, 1259\u20131261 (2014).","journal-title":"J. Clin. Microbiol."},{"key":"96383_CR15","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1469-0691.2008.01997.x","volume":"14","author":"M Kaase","year":"2008","unstructured":"Kaase, M. et al. Comparison of phenotypic methods for penicillinase detection in staphylococcus aureus. Clin. Microbiol. Infect. 14, 614\u2013616 (2008).","journal-title":"Clin. Microbiol. Infect."},{"key":"96383_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.diagmicrobio.2012.07.013","volume":"74","author":"RE El Feghaly","year":"2012","unstructured":"El Feghaly, R. E., Stamm, J. E., Fritz, S. A. & Burnham, C. A. D. Presence of the blaZ beta-lactamase gene in isolates of Staphylococcus aureus that appear penicillin susceptible by conventional phenotypic methods. Diagn. Microbiol. Infect. Dis. 74, 388\u2013393 (2012).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"96383_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/phar.2124","volume":"38","author":"MD Shah","year":"2018","unstructured":"Shah, M. D., Wardlow, L. C., Stevenson, K. B., Coe, K. E. & Reed, E. E. Clinical outcomes with penicillin versus alternative \u03b2-lactams in the treatment of penicillin-susceptible staphylococcus aureus bacteremia. Pharmacotherapy 38, 769\u2013775 (2018).","journal-title":"Pharmacotherapy"},{"key":"96383_CR18","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/jac\/dkt108","volume":"68","author":"JL Nissen","year":"2013","unstructured":"Nissen, J. L. et al. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: A retrospective, propensity-score-adjusted case\u2013control and cohort analysis. J. Antimicrob. Chemother. 68, 1894\u20131900 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"96383_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jiac.2019.10.023","volume":"26","author":"Y Moriyama","year":"2020","unstructured":"Moriyama, Y., Ishikane, M., Mezaki, K. & Ohmagari, N. Comparison of penicillins (Penicillin g and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible staphylococcus aureus (Pssa) bacteremia in Japan: A retrospective cohort study. J. Infect. Chemother. 26, 358\u2013362 (2020).","journal-title":"J. Infect. Chemother."},{"key":"96383_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10096-021-04330-2","volume":"41","author":"G Reynolds","year":"2022","unstructured":"Reynolds, G., Crawford, S., Cuenca, J., Ghosh, N. & Newton, P. Penicillin versus anti-staphylococcal beta-lactams for penicillin-susceptible staphylococcus aureus blood stream infections: A retrospective cohort study. Eur. J. Clin. Microbiol. Infect. Dis. 41, 147\u2013151 (2022).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"96383_CR21","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/jac\/dkad263","volume":"78","author":"HT Mok","year":"2023","unstructured":"Mok, H. T. et al. Treatment outcomes with benzylpenicillin and non-benzylpenicillin antibiotics, and the performance of the penicillin zone-edge test versus molecular detection of blaZ in penicillin-susceptible Staphylococcus aureus (Pssa) bacteraemia. J. Antimicrob. Chemother. 78, 2515\u20132523 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"96383_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijantimicag.2019.05.020","volume":"54","author":"A Henderson","year":"2019","unstructured":"Henderson, A. et al. Benzylpenicillin versus flucloxacillin for penicillin-susceptible staphylococcus aureus bloodstream infections from a large retrospective cohort study. Int. J. Antimicrob. Agents 54, 491\u2013495. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.05.020 (2019).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"96383_CR23","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1093\/ofid\/ofaa439.344","volume":"7","author":"M Aldhaeefi","year":"2020","unstructured":"Aldhaeefi, M., Pearson, J., Kanjilal, S. & Dionne, B. Penicillin versus cefazolin or anti-staphylococcal penicillins for penicillin-susceptible staphylococcus aureus bacteremia. Open Forum Infect. Dis. 7, S149 (2020).","journal-title":"Open Forum Infect. Dis."},{"key":"96383_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 40, 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"key":"96383_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","volume":"11","author":"JW Chow","year":"1999","unstructured":"Chow, J. W. & Yu, V. L. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: A commentary. Int. J. Antimicrob. Agents. 11, 7\u201312 (1999).","journal-title":"Int. J. Antimicrob. Agents."},{"key":"96383_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jac\/47.2.129","volume":"47","author":"R Dagan","year":"2001","unstructured":"Dagan, R. Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J. Antimicrob. Chemother. 47, 129\u2013140 (2001).","journal-title":"J. Antimicrob. Chemother."},{"key":"96383_CR27","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.1128\/AAC.04677-14","volume":"59","author":"SN Rao","year":"2015","unstructured":"Rao, S. N. et al. Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible staphylococcus aureus bloodstream infections. Antimicrob. Agents Chemother. 59, 5232\u20135238 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"96383_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1542-4758.2010.00507.x","volume":"15","author":"CJ Renaud","year":"2011","unstructured":"Renaud, C. J., Lin, X., Subramanian, S. & Fisher, D. A. High-dose cefazolin on consecutive hemodialysis in anuric patients with Staphylococcal bacteremia. Hemodial. Int. 15, 63\u201368 (2011).","journal-title":"Hemodial. Int."},{"key":"96383_CR29","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1128\/AAC.00485-11","volume":"55","author":"S Lee","year":"2011","unstructured":"Lee, S. et al. Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible staphylococcus aureus bacteremia?. Antimicrob. Agents Chemother. 55, 5122\u20135126 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"96383_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ van Hal","year":"2012","unstructured":"van Hal, S. J. et al. Predictors of mortality in staphylococcus aureus bacteremia. Clin. Microbiol. Rev. 25, 362\u2013386 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"96383_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jinf.2018.08.015","volume":"77","author":"K Nambiar","year":"2018","unstructured":"Nambiar, K. et al. Survival following staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care. J. Infect. 77, 516\u2013525 (2018).","journal-title":"J. Infect."},{"key":"96383_CR32","volume":"147","author":"JA Roth","year":"2017","unstructured":"Roth, J. A., Tschudin-Sutter, S., Dangel, M., Frei, R. & Battegay, M. Value of the pitt bacteraemia score to predict short-term mortality in Staphylococcus aureus bloodstream infection: A validation study. Swiss Med. Weekly 147, w14482 (2017).","journal-title":"Swiss Med. Weekly"},{"key":"96383_CR33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/cid\/cis889","volume":"56","author":"E Forsblom","year":"2013","unstructured":"Forsblom, E., Ruotsalainen, E., Ollgren, J. & J\u00e4rvinen, A. Telephone consultation cannot replace bedside infectious disease consultation in the management of staphylococcus aureus bacteremia. Clin. Infect. Dis. 56, 527\u2013535 (2013).","journal-title":"Clin. Infect. Dis."},{"key":"96383_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10096-023-04557-1","volume":"42","author":"M Papadimitriou-Olivgeris","year":"2023","unstructured":"Papadimitriou-Olivgeris, M., Caruana, G., Senn, L. & Guery, B. Predictors of mortality of staphylococcus aureus bacteremia among patients hospitalized in a Swiss University Hospital and the role of early source control; A retrospective cohort study. Eur. J. Clin. Microbiol. Infect. Dis. 42, 347\u2013357 (2023).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"96383_CR35","unstructured":"Lewis, J. S. Performance Standards for Antimicrobial Susceptibility Testing. 34th ed. Clinical and Laboratory Standards Institute (2024)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96383-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T02:01:20Z","timestamp":1744596080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96383-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96383"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96383-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved with a waiver of informed consent by the National Healthcare Group Domain Specific Review Board (reference number: 2023\/00,149, 2015\/01111). All methods were performed in accordance with the Declaration of Helsinki and other relevant guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"12103"}}